Journal article icon

Journal article : Comment

D-amino acid oxidase inhibition: A new glutamate twist for clozapine augmentation in schizophrenia?

Abstract:

Despite clozapine, many patients with schizophrenia remain treatment-resistant. Unfortunately, after many clinical trials with a diverse range of agents, there remain no evidence-based clozapine augmentation strategies. Against this background, the positive results of the randomised, double-blind, placebo-controlled trial of adjunctive sodium benzoate reported by Lin et al (1; this issue) are extremely welcome, and complement their earlier trial showing similar benefits in patients taking ot...

Expand abstract
Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Files:
Publisher copy:
10.1016/j.biopsych.2018.06.001

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Oxford college:
Wolfson College
Role:
Author
ORCID:
0000-0002-6719-1126
Medical Research Council More from this funder
National Institute for Health Research More from this funder
Wellcome Trust More from this funder
Publisher:
Elsevier Publisher's website
Journal:
Biological Psychiatry Journal website
Volume:
84
Issue:
6
Pages:
396-398
Publication date:
2018-08-27
Acceptance date:
2018-06-05
DOI:
EISSN:
1873-2402
ISSN:
0006-3223
Source identifiers:
857231
Subtype:
Comment
Pubs id:
pubs:857231
UUID:
uuid:a5bd7046-6afd-420b-a851-c56188951873
Local pid:
pubs:857231
Deposit date:
2018-06-15

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP